DRD2 and schizophrenia: However, dopamine signalling is heavily implicated in schizophrenia, in part because all antipsychotic drugs in clinical use target the dopamine D2 receptor68, while DRD2 is located at a genetic locus repeatedly found to associate with schizophrenia1,2 and also with depression6.